Curcumin has therapeutic value in patients with monoclonal gammopathy, a possible precursor to multiple myeloma. - GreenMedInfo Summary

Abstract Title:

The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker.

Abstract Source:

Clin Cancer Res. 2009 Sep 15;15(18):5917-22. Epub 2009 Sep 8. PMID: 19737963

Abstract Author(s):

Terry Golombick, Terrence H Diamond, Vladimir Badmaev, Arumugam Manoharan, Rajeev Ramakrishna

Article Affiliation:

Department of Endocrinology, St. George Hospital, Sydney and Southern Sydney Haematology, University of Wollongong, New South Wales, Australia. terry.golombick@sesiahs.health.nsw.gov.au

Abstract:

PURPOSE: To determine the effect of curcumin on plasma cells and osteoclasts in patients with MGUS.

EXPERIMENTAL DESIGN: Twenty-six patients with MGUS were recruited into the study and administered 4 grams/day oral curcumin. Blood and urine samples were collected at specified visits after initiating therapy. Full blood count, B2 microglobulin, serum paraprotein, and immunoglobulin electrophoresis (IEPG and EPG) were determined for all patients at each visit. Serum calcium, 25 hydroxyvitamin D3, and bone-specific alkaline phosphatase were determined at baseline only. Urine, as a morning second-void sample, was collected at each visit for urinary N-telopeptide of type I collagen.

RESULTS: Our results show that oral curcumin is able to decrease paraprotein load in a select group (i.e., those having a paraprotein level of>20 g/L) of patients with MGUS. Fifty percent (5 of 10) of these patients had a 12% to 30% reduction in their paraprotein levels, while on curcumin therapy. In addition, 27% of patients on curcumin had a>25% decrease in urinary N-telopeptide of type I collagen.

CONCLUSION: Due to the possible progression of MGUS to multiple myeloma, the potential role of curcumin as a therapeutic intervention for MGUS patients warrants further investigation.

Article Published Date : Sep 15, 2009
Study Type : Human Study
Additional Links
Substances : Curcumin : CK(2923) : AC(1482)
Diseases : Monoclonal Gammopathies : CK(10) : AC(1), Multiple Myeloma : CK(156) : AC(53)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Facebook Comments

GMI Comments

Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.